in English language and which investigated medication adherence in pediatric transplantation were included. The type of organ and the methods used to assess medication adherence were studied. Results: A total of 281 records were identified, from which 34 studies were selected: 38% (n=13) on kidney transplantation, 32% (n=11) on liver transplantation, and 23% (n=10) on the transplantation of other organs. Medication adherence was found to be lower than 80% in twothirds of the studies (64%), and varied from 22% to 97%. This wide range was explained in part by the important heterogeneity of assessment methods among studies. The methods used were objective, non-objective, or combined both types. Most studies did not fully describe the data collected: the time since transplantation, the period over which adherence was assessed, the population, the medications, and the threshold discriminating adherence and non-adherence. Conclusion: The present study found poor medication adherence in the pediatric population posttransplantation. There was a wide range of medication adherence, explained largely by the heterogeneity of assessment methods. Future studies must consider the characteristics of each methodology, but also the threshold defining adherence should be chosen on the basis of clinical outcomes, and describe all data collected to gain precision. To improve adherence in this population, it is essential to identify factors influencing medication (IT and concomitant medications) adherence.
Introduction
Adherence is defined "as the extent to which a person's behavior [. . .] corresponds with agreed recommendations from a health care provider". Medication adherence averages 50% among adults suffering from chronic diseases, and as poor medication adherence compromises the therapeutic approach it is a major concern in public health.
hospitalization is increased by 60%, and that of organ loss by 80% when patients considered non-adherent to IT. 6 Medication adherence is therefore a major concern in pediatrics. In 2009, Dew et al 49 published a meta-analysis that investigated medical regimen adherence after SOT in a pediatric population; the authors included studies that reported non-adherence to IT and/or clinical appointments. The authors concluded that there was a wide range of IT adherence rates due to the heterogeneity of methodological aspects and analysis of data in published studies. However, there is no recent systematic review that has investigated adherence to both IT and concomitant medications in a pediatric population after both SOT and HSCT. The aim of the present review was therefore to report on medication adherence in pediatric populations after both SOT and HSCT. This will provide an overview in this particular population, and a special focus will be made on the assessment methods used, which can be objective methods such as drug assays, and non-objective methods such as questionnaires.
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Methods
The MEDLINE database was searched for relevant studies published from January 1, 1999 to January 1, 2016 using the following search strategy: ("patient compliance" [Mesh] OR "medication adherence" [Mesh] OR medication compliance) AND (pediatr* OR child) AND (transplan*). The inclusion criteria were: studies in English language, reporting on pediatric transplant patients (age <21 years at the time of transplantation), measuring medication adherence, and describing the assessment method of medication adherence. Case reports, editorials, letters, and syllabi were excluded. Systematic and non-systematic reviews, as well as meta-analysis were excluded but checked for additional studies. 11, 49 The selection was independently reviewed by two of the authors (DH and AJD), and disagreements were resolved by consensus. The analysis of selected studies consisted of description of organs, mean time since transplantation, population, medications; the methods used to assess medication adherence were also investigated.
Results
The first search strategy found 281 records; 221 were excluded because they did not talk about medication adherence in pediatric transplantation. A further 19 studies were excluded because a measure of medication adherence was not reported, and 7 because results obtained in pediatric subjects were not reported separately from other populations ( Figure 1) . Thus, 34 studies were included.
Thirteen studies concerned kidney transplantation (Table 1) , and 11 liver transplantation (Table 2 ). Other studies reported IT adherence in heart transplantation (Table 3) , HSCT ( Figure 1 Review inclusion and exclusion flowchart followed PRISMA guidelines. different organs in the same study (multi-organ studies) (Table 5) . Among all types of organ, medication adherence ranged from 22% 19 to 97%. 21 Medication adherence was found to be lower than 80% in 22 studies, between 80% and 90% in 5 studies, 8, 12, 14, 23, 24 and 90% or greater in 7 studies. 16, 18, 21, 32, 34, 37, 42 Among these 7 studies, 3 focused on kidneys, 16 ,18,21 1 on liver, 32 1 on heart, 34 and 2 were multi-organ. 37, 42 Twenty studies reported the mean time of medication adherence measurement since transplantation, which ranged from 27 days 35 to 9.4 years. 31, 33 The majority of these studies (n=12) examined medication adherence 5 years or later after transplantation, and among these medication adherence ranged from 27% 31 to 97% . 37 The majority of studies (n=23) reported data for adolescents (≥10 years of age) only. Two studies reported data for children, in whom adherence was 30% 41 and 91%. 34 One study stratified according to the patient's age, and concluded that medication adherence was poorer among adolescents (65%) than in children (81%).
12
All included studies concerned IT. Twenty-two studies measured adherence to cyclosporine (CsA), 26 to tacrolimus (Tac), and 21 to both CsA and Tac. Three studies measured also concomitant medications: antibiotics, antivirals, antihypertensives for instance, without separated IT and concomitant medication adherence measures. 35, 41, 42 One study compared IT to concomitant medications: IT adherence was poorer (60% vs 80%). 41 
Assessment methodologies
Period over which adherence was assessed 
Objective methods
Thirty-one studies assessed medication adherence using objective methods: drug assays (n=21), MEMS (n=6), MPR (n=2). A total of 21 studies used drug assays (Table 6 ) among which 2 did not mention the type of drug assay (level or SD). 32, 36 The 21 other studies considered either drug or metabolite levels in plasma, serum, or blood (n=10), and/or the SD that reports drug or metabolite levels over a period of time (n=11). SD studies (performed only for Tac) found medication adherence from 27% 38 to 90%. 41 Studies using levels reported medication adherence that ranged from 27% 31 to 84%. 14 Six other studies used MEMS, 13, 20, 21, 35, 37, 40 which is a specific medication device recording date and timing of each use, and reported medication adherence ranged from 69% 37 to 79% 21 (Table 6 ).Two studies used MPR: medication adherence reported was 56% 15 and 92%.
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Non-objective methods
Twenty studies assessed medication adherence by nonobjective methods: questionnaires or interviews (n=16), the opinion of physicians and/or nurses (n=4), retrospective chart review (RCR; n=3). RCR evaluated the number of patient records documenting medication non-adherence: the medication adherence reported in the 3 studies was 50%, 28 62%, 27 and 91%. 34 Among the 4 studies using the opinion of physicians and/or nurses, 13 
Discussion
To the best of our knowledge, this is the first time a systematic review has focused on medication adherence in a pediatric population after both SOT and HSCT. A total of 34 studies investigated medication adherence after transplantation over the last 16 years in pediatric populations, which is low considering the number of studies in other chronic diseases. 44 Irrespective of the transplanted organ, medication adherence ranged widely among studies. It remained poor with two-thirds studies (64%) describing medication adherence lower than 80%, highlighting the importance of considering medication adherence in the pediatric population post-transplantation. Data for HSCT, a relatively frequent procedure, is reported only in one study, 35 whereas two studies reported data for heart-lung transplantation which is a rare procedure. 34, 36 This may be related to the short period required of IT after HSCT, as compared to the indefinite period required after SOT. Nevertheless, IT is essential for good prognosis after HSCT, 5 and it is therefore of great interest to evaluate medication adherence after such transplantations. All studies in this review investigated adherence to IT, underlining the importance of this concern in the posttransplantation period. Despite the need for an effective prevention of infections after transplantation, for instance, only 3 studies reported adherence to concomitant medications such as antibiotics. 35, 41, 42 In adults, Russel et al have considered that adherence to a medicationmeasured by MEMS -allowed the extrapolation of results to the comedications. 45 However in pediatrics, it is more appropriate to evaluate medication adherence for individual drugs 41, 46 as aspects such as medication flavor or form (syrup or pill) could cause different behaviors in children. 7 It would be interesting that the 3 studies found in this review did compare IT adherence to concomitant medication adherence. Most studies reported data for adolescents, which reflects a concern regarding medication adherence in this specific population after SOT and HSCT. Only one study compared data for children and adolescents, which is regrettable. This study revealed that medication adherence in children (81%) is higher than in adolescents (65%). 12 The adolescence period of life is known to decrease medication adherence by several reasons; 7 for instance, Dobbels et al enunciate the transition to adulthood health care system as an important factor of non-adherence during adolescence. 10 This is confirmed by a study included in this present review which found that IT adherence after transition (32%) is lower than before (68%). 32 In addition, adolescence is a time when difficulties in the parentpatient relationship are important. 7 Regarding it, the unfrequent comparison of adolescent and caregiver reports on medication adherence (3 studies in this review using subjective methods) would be interested to consider more. An important aspect to consider when interpreting data is the measurement method employed. At the time of writing no "gold standard" method exists, 1, 7 which explains the heterogeneity of those used in this review. Surprisingly, 16 studies used only 1 method whereas it is known that no single method is optimal. 1, 7 For example, Non-adherence is defined as any self-reported non-adherence (response score [1] [2] [3] [4] [5] on any of the four items [BAASIS questionnaire]. the four trough blood levels for cyclosporine or tacrolimus preceding the data collection were retrieved from the medical charts, with a tacrolimus trough level below 5 ng/mL, and a cyclosporine level below 100 ng/mL on at least one measurement being indicative for non-adherence
MNA
Combined:
Questionnaire BAASIS (patient/caregiver); drug assay by levels (Tac>5, CsA>100 ng/mL); Gradual physician's opinion Those patients who reported forgeting to take their medications regularly in response to a specifiqc quetsion on the BMQ questionnaire were considered to be unintentionnaly non-adherent. The second response was non-adherence which had been specified in the medical notes and which had been documented by the consultatn cardiologist as intentional non-adherence "Participants who missed or were late in taking 10% or more of their prescribed doses in the past week were classified as " non-adherent" (..)
Based on these empirically derived out-of-target ranges, participants were coded as "nonadherent" if they had at least one serum levels that fell out of the target ranges (high or low levels for CsA, SrL, Tac, or >3 s.d. for Tac) and adherent if all levels were within the specified ranges." drug assays will not detect patients who take their medications only before clinical visits. Conversely, MEMS is a longitudinal method taking into account "drug holidays" (when a patient discontinues medication of his/her own accord). Nevertheless, patients cannot be blinded to MEMS; it interferes with daily life and causes anxiety. 45 In pediatric patients, all these methods have additional drawbacks. For instance, MEMS-based studies may be too difficult to be feasible in pediatric patients who are unable to take pills, 20, 21, 35, 40 and drug assay methods are invasive so this may be a limiting factor in pediatric patients. 46 Yet, 23 of the 34 studies used this method, which could indicate that this is not a drawback too hard to surpass. In this review, only 10 studies (32%) used combined methods -4 were published before 2005 and 6 after 2008 -suggesting that this is yet to become the preferred method. Among these studies, only a minority described precisely the combination method although this is essential to interpret data as the different combination techniques have different aims. One of the combination techniques has a high sensitivity: it underestimates medication adherence but misses less frequently non-adherent patients. 19, 41 Whereas the other combination technique used a well-balanced score (MACS), 38, 43 which allows categorization of patients according to their adherence. 47 An additional difficulty for the interpretation of data in the present review is the definition of medication adherence which differed between each selected study, as synthetized in the Supplementary material (Table 7) . It is interesting to note that many studies did not define a threshold discriminating medication adherence and non-adherence, and when they did so this was rarely based on clinical outcomes. Generally, 80% of taken medication is the arbitrary threshold discriminating medication adherence and non-adherence. 1 To be relevant this threshold should be correlated to clinical outcomes, which was a posteriori investigated in 2 studies included herein; these found a close relationship between IT adherence and graft survival (p=0.017; 18 p=0.02
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) and also mortality (p=0.009). 48 Also, Stuber et al 30 constructed ROC curve to try answering about the appropriate SD cut-off for Tac.
Limitations
This review included studies from the MEDLINE database only. Given the topic of this review, studies are essentially published in PubMed and research on other database is unlikely to have added additional relevant articles. An additional point is that this review is not a meta-analysis. Dew Ma et al published a meta-analysis in 2009 focusing on medication adherence after pediatric SOT only. 49 The authors recognized that there was a lack of studies in certain transplantation types (lung, intestine) and noted the heterogeneity in published articles concerning methodological aspects and the analysis of data. This still seems to be the case 10 years later.
Conclusion
This review revealed the poor medication adherence in the pediatric population post-transplantation, and underlined also the wide range of medication adherence reported in the literature. The heterogeneity of assessment methods explained at least in part this wide range found. Future studies must weigh the advantages and disadvantages of each methodology and describe all data collected to gain precision. It is also essential that the threshold discriminating adherence and non-adherence must be chosen on the basis of clinical outcomes. Beyond the observation of poor medication adherence, there is an obvious need to improve this situation. For that it is essential to identify factors of medication non-adherence to propose adapted interventions and so try to improve medication adherence in adolescents and children after SOT and HSCT.
